RxSight (RXST) Stock Statistics & Valuation Metrics

RxSight has a market cap or net worth of $577.45M. The enterprise value is $383.64M.

RxSight has 40,636,982 shares outstanding. The number of shares has decreased by -2.65% in one year.

RxSight’s return on equity (ROE) is -0.10 and return on invested capital (ROIC) is -12.57%.

The current PE Ratio of RxSight is -48.67. RxSight’s PEG ratio is -0.15.

In the last 12 months, RxSight had revenue of 139.93M and earned -27.45M in profits. Earnings per share was -0.71.

In the last 12 months, operating cash flow was -16.55M and capital expenditures -4.05M, giving a free cash flow of -20.60M billion.

RxSight pays an annual dividend of ―, resulting in a dividend yield of ―

RxSight upcoming earnings date is Aug 11, 2025, TBA Not Confirmed.

RxSight as a current ratio of 11.36, with Debt / Equity ratio of 50.05%

In the past 12 months, RxSight has paid 50.00K in taxes.

RxSight EV to EBITDA ratio is -56.05, with an EV/FCF ratio of -59.50.

RxSight has $229.34M in cash and marketable securities with $12.04M in debt, giving a net cash position of -$217.30M billion.

Gross margin is 43.52%, with operating margin of -26.34%, and net profit margin of -19.62%.

The average price target for RxSight is $22.56, which is 11.43% higher than the current price. The consensus rating is Hold